查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1320016

蛋白质治疗市场：按蛋白质功能、产品类型划分 - 2023-2030 年全球预测

Protein Therapeutics Market by Protein Function, Product Type - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球蛋白质治疗市场预计到 2023 年将大幅成长 786.6 亿美元，复合年增长率为 7.88%，到 2030 年将达到惊人的 1,339.8 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球蛋白质治疗市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 蛋白质疗法的全球市场规模与预测为何？

2.在预测期内，COVID-19对全球蛋白质治疗市场的阻碍因素与影响为何？

3. 在预测期内，全球蛋白质治疗市场需要投资哪些产品/细分市场/应用/领域？

4. 全球蛋白质治疗市场的竞争策略是什么？

5. 全球蛋白质治疗市场的技术趋势和法律规范是什么？

6. 全球蛋白质治疗市场主要供应商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入全球蛋白质治疗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 新兴市场医疗保健支出不断增加
      • 政府配合措施改善医疗服务
      • 老年人口增加和慢性病盛行率上升
    • 抑制因素
      • 蛋白质疗法的局限性，包括生产成本高和组织渗透效率低的大蛋白质
      • 由于肠道变性，对口服药物可用性的担忧
    • 机会
      • 双特异性单株抗体的潜力
      • 新兴国家未满足的医疗需求
    • 任务
      • 製造加工成本高
      • 与生物相似药的竞争
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章依蛋白质功能分類的蛋白质治疗药物市场

  • 酶和调节
  • 蛋白质诊断
  • 疫苗

第7章蛋白质治疗市场：依产品类型

  • 凝血因子
  • 促红血球生成素
  • 卵泡刺激素
  • G-CSF
  • 胰岛素
  • 干扰素
  • 单株抗体

第8章美洲蛋白质治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太蛋白质治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲蛋白质治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-035AB9C0DA42

The Global Protein Therapeutics Market is forecasted to grow significantly, with a projected USD 78.66 billion in 2023 at a CAGR of 7.88% and expected to reach a staggering USD 133.98 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Protein Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Protein Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines. The Protein Diagnostics is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies. The Monoclonal Antibodies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Protein Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Protein Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?

6. What is the market share of the leading vendors in the Global Protein Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Protein Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Protein Therapeutics Market, by Protein Function, 2022 vs 2030
  • 4.3. Protein Therapeutics Market, by Product Type, 2022 vs 2030
  • 4.4. Protein Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
      • 5.1.1.2. Government initiatives to improve the healthcare services
      • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
      • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential for bispecific monoclonal antibodies
      • 5.1.3.2. Unmet medical needs in developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of production and treatment
      • 5.1.4.2. Competition from biosimilars
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Protein Therapeutics Market, by Protein Function

  • 6.1. Introduction
  • 6.2. Enzymatic & Regulatory
  • 6.3. Protein Diagnostics
  • 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Blood Clotting Factor
  • 7.3. Erythropoietin
  • 7.4. Follicle Stimulating Hormone
  • 7.5. G-CSF
  • 7.6. Insulin
  • 7.7. Interferons
  • 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. PROTEIN THERAPEUTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2030 (%)
  • FIGURE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. PROTEIN THERAPEUTICS MARKET DYNAMICS
  • FIGURE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC & REGULATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 103. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 104. PROTEIN THERAPEUTICS MARKET LICENSE & PRICING